Literature DB >> 18037879

Identification and targeting of the ROSA26 locus in human embryonic stem cells.

Stefan Irion1, Hervé Luche, Paul Gadue, Hans Joerg Fehling, Marion Kennedy, Gordon Keller.   

Abstract

The derivation of human embryonic stem (hES) cells has opened new avenues for studies on human development and provided a potential source of cells for replacement therapy. To reveal the full potential of hES cells, it would be advantageous to be able to genetically alter them as is routinely done with mouse ES cells through homologous recombination. The mouse Rosa26 locus is particularly useful for genetic modification as it can be targeted with high efficiency and is expressed in most cell types tested. Here we report the identification of the human homolog of the mouse Rosa26 locus. We demonstrate targeting of a red-fluorescent protein (tdRFP) cDNA to this locus through homologous recombination and expression of this targeted reporter in multiple hES cell-derived lineages. Through recombinase-mediated cassette exchange, we show replacement of the tdRFP cDNA with other cDNAs, providing a cell line in which transgenes can be readily introduced into a broadly expressed locus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18037879     DOI: 10.1038/nbt1362

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  112 in total

Review 1.  Find and replace: editing human genome in pluripotent stem cells.

Authors:  Huize Pan; Weiqi Zhang; Weizhou Zhang; Guang-Hui Liu
Journal:  Protein Cell       Date:  2011-12-15       Impact factor: 14.870

Review 2.  Safe harbours for the integration of new DNA in the human genome.

Authors:  Michel Sadelain; Eirini P Papapetrou; Frederic D Bushman
Journal:  Nat Rev Cancer       Date:  2011-12-01       Impact factor: 60.716

3.  Repeated integration of antibody genes into a pre-selected chromosomal locus of CHO cells using an accumulative site-specific gene integration system.

Authors:  Yoshinori Kawabe; Hirokatsu Makitsubo; Yujiro Kameyama; Shuohao Huang; Akira Ito; Masamichi Kamihira
Journal:  Cytotechnology       Date:  2011-09-25       Impact factor: 2.058

4.  Tracking differentiating neural progenitors in pluripotent cultures using microRNA-regulated lentiviral vectors.

Authors:  Rohit Sachdeva; Marie E Jönsson; Jenny Nelander; Agnete Kirkeby; Carolina Guibentif; Bernhard Gentner; Luigi Naldini; Anders Björklund; Malin Parmar; Johan Jakobsson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

5.  Gene correction in human embryonic and induced pluripotent stem cells: promises and challenges ahead.

Authors:  Kazim H Narsinh; Joseph C Wu
Journal:  Mol Ther       Date:  2010-06       Impact factor: 11.454

Review 6.  Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.

Authors:  Ying Liu; Wenbin Deng
Journal:  Brain Res       Date:  2015-09-28       Impact factor: 3.252

7.  Fluorescent labeling of endogenous platelets for intravital microscopy: Effects on platelet function.

Authors:  Qi Da; Paul J Derry; Fong W Lam; Rolando E Rumbaut
Journal:  Microcirculation       Date:  2018-05-30       Impact factor: 2.628

8.  Hydrophobic surfaces for enhanced differentiation of embryonic stem cell-derived embryoid bodies.

Authors:  Bahram Valamehr; Steven J Jonas; Julien Polleux; Rong Qiao; Shuling Guo; Eric H Gschweng; Bangyan Stiles; Korey Kam; Tzy-Jiun M Luo; Owen N Witte; Xin Liu; Bruce Dunn; Hong Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-12       Impact factor: 11.205

Review 9.  Technical challenges in using human induced pluripotent stem cells to model disease.

Authors:  Krishanu Saha; Rudolf Jaenisch
Journal:  Cell Stem Cell       Date:  2009-12-04       Impact factor: 24.633

10.  Stem cells in development of therapeutics for Parkinson's disease: a perspective.

Authors:  Jiajie Xi; Su-Chun Zhang
Journal:  J Cell Biochem       Date:  2008-12-01       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.